Social Determinants of Health, Clinical Outcomes, and Healthcare Resource Utilization in Participants With and Without Narcolepsy in the All of Us Research Program

Clicks: 3
ID: 323813
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #33 of 39 articles by views in SLEEP Advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Study Objectives Evaluate the clinical and economic burden and impact of social determinants of health (SDoH) in narcolepsy. Methods This retrospective, observational study used electronic health record and survey data from the All of Us Research Program (1/1/2009–7/31/2022). Participants with narcolepsy were matched 1:3 to participants without narcolepsy. Descriptive statistics and regression analyses (odds ratios [ORs]) summarized demographics, clinical comorbidities, and SDoH; hazard ratios (HRs) estimated risk of incident hypertension, hyperlipidemia, obesity, and coronary arteriosclerosis (CA); and incidence rate ratios (IRRs) estimated healthcare resource utilization (HCRU). Results The sample comprised 2766 participants (narcolepsy, n=694; non-narcolepsy, n=2072; mean age, 49 years; 70% female). Despite high education levels, greater proportions were out of work/the workforce in the narcolepsy versus non-narcolepsy cohort (38.5% vs 29.2%). Among SDoH survey respondents, greater food insecurity, loneliness, and everyday/medical discrimination, and less social support/cohesion were reported in the narcolepsy (n=259) versus non-narcolepsy (n=768) cohort. Individuals with versus without narcolepsy had higher odds (OR [95% confidence interval; CI]) of cardiovascular (1.76 [1.35–2.28]), cardiometabolic (2.12 [1.73–2.59]), and renal (2.47 [1.72–3.56]) comorbidities; higher risk (HR [95% CI]) of developing hypertension (2.00 [1.51–2.65]), hyperlipidemia (1.96 [1.52–2.54]), obesity (2.42 [1.93–3.05]), and CA (1.75 [1.27–2.42]); and increased HCRU (IRR [95% CI]) for inpatient days (2.07 [1.55–2.78]), outpatient visits (1.51 [1.35–1.70]), and emergency department visits (1.70 [1.19–2.43]). Conclusions Narcolepsy is associated with employment barriers, SDoH-related disparities, and elevated comorbidity burden and risk. Comprehensive and timely management strategies are needed to address whole-person health.
Reference Key
openalex_W7172513839 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sarah C. Markt, C. Drachenberg, Anan Zhou, Katarina Irwin, Silky Beaty, Jon Michael Stroh, Martin Zagari, Jessica K. Alexander, M. Whalen, Junko Saber, B. R. Hutchinson
Journal SLEEP Advances
Year 2026
DOI
10.1093/sleepadvances/zpag088
URL
https://doi.org/10.1093/sleepadvances/zpag088
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.